Guardant Historical Income Statement
| GH Stock | USD 35.40 2.75 8.42% |
Historical analysis of Guardant Health income statement accounts such as Interest Income of 37.1 M can show how well Guardant Health performed in making a profits. Evaluating Guardant Health income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Guardant Health's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Guardant Health latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Guardant Health is a good buy for the upcoming year.
Guardant |
About Guardant Income Statement Analysis
Guardant Health Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Guardant Health shareholders. The income statement also shows Guardant investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Guardant Health Income Statement Chart
Add Fundamental
Total Revenue
Total revenue comprises all receipts Guardant Health generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Guardant Health minus its cost of goods sold. It is profit before Guardant Health operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Most accounts from Guardant Health's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Guardant Health current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Guardant Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.As of now, Guardant Health's Depreciation And Amortization is increasing as compared to previous years. The Guardant Health's current Interest Expense is estimated to increase to about 2.8 M, while Selling General Administrative is projected to decrease to under 118.7 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Depreciation And Amortization | 22.3M | 36.0M | 42.9M | 45.0M | Interest Income | 3.9M | 6.1M | 35.4M | 37.1M |
Guardant Health income statement Correlations
Click cells to compare fundamentals
Guardant Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Guardant Health income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Tax Provision | (1.9M) | 379K | 300K | 1.1M | 685K | 719.3K | |
| Net Interest Income | 12.6M | 5.4M | 1.4M | 3.5M | 32.8M | 34.4M | |
| Interest Income | 13.7M | 10.2M | 3.9M | 6.1M | 35.4M | 37.1M | |
| Depreciation And Amortization | 13.8M | 16.1M | 22.3M | 36.0M | 42.9M | 45.0M | |
| Interest Expense | 1.3M | 1.2M | 4.8M | 2.6M | 2.6M | 2.8M | |
| Selling General Administrative | 61.4M | 192.8M | 206.6M | 164.0M | 155.8M | 118.7M | |
| Selling And Marketing Expenses | 78.3M | 106.5M | 191.9M | 299.8M | 295.2M | 149.0M | |
| Total Revenue | 214.4M | 286.7M | 373.7M | 449.5M | 563.9M | 282.4M | |
| Gross Profit | 143.7M | 194.2M | 250.7M | 293.2M | 336.9M | 177.0M | |
| Other Operating Expenses | 296.7M | 541.7M | 784.7M | 993.9M | 1.1B | 567.2M | |
| Operating Income | (82.4M) | (255.0M) | (411.0M) | (544.4M) | (564.7M) | (536.5M) | |
| Net Income From Continuing Ops | (67.9M) | (246.3M) | (384.8M) | (654.6M) | (479.4M) | (455.5M) | |
| Ebit | (82.4M) | (241.1M) | (381.9M) | (650.9M) | (476.2M) | (452.4M) | |
| Research Development | 86.3M | 149.9M | 263.2M | 373.8M | 367.2M | 385.6M | |
| Ebitda | (68.5M) | (225.1M) | (359.6M) | (614.9M) | (433.3M) | (411.6M) | |
| Cost Of Revenue | 70.7M | 92.5M | 122.9M | 156.3M | 227.1M | 238.4M | |
| Total Operating Expenses | 226.0M | 449.1M | 661.7M | 837.6M | 901.6M | 461.8M | |
| Income Before Tax | (69.7M) | (245.9M) | (384.5M) | (653.4M) | (478.8M) | (454.8M) | |
| Total Other Income Expense Net | 12.6M | 9.0M | 26.5M | (109.1M) | 86.0M | 90.3M | |
| Net Income Applicable To Common Shares | (75.7M) | (253.8M) | (405.7M) | (654.6M) | (589.1M) | (559.7M) | |
| Net Income | (67.9M) | (246.3M) | (384.8M) | (654.6M) | (479.4M) | (455.5M) | |
| Income Tax Expense | (1.9M) | 379K | 300K | 1.1M | 685K | 719.3K | |
| Reconciled Depreciation | 13.6M | 16.1M | 22.3M | 36.0M | 42.9M | 22.5M | |
| Non Operating Income Net Other | 13.8M | 13.8M | 29.1M | (106.5M) | (95.8M) | (91.1M) |
Currently Active Assets on Macroaxis
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Guardant Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardant Health. If investors know Guardant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardant Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.28) | Revenue Per Share 5.7 | Quarterly Revenue Growth 0.339 | Return On Assets (0.16) | Return On Equity (6.09) |
The market value of Guardant Health is measured differently than its book value, which is the value of Guardant that is recorded on the company's balance sheet. Investors also form their own opinion of Guardant Health's value that differs from its market value or its book value, called intrinsic value, which is Guardant Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardant Health's market value can be influenced by many factors that don't directly affect Guardant Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardant Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardant Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardant Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.